Aging of cerebral white matter
White matter (WM) occupies a large volume of the human cerebrum and is mainly composed
of myelinated axons and myelin-producing glial cells. The myelinated axons within WM are …
of myelinated axons and myelin-producing glial cells. The myelinated axons within WM are …
[HTML][HTML] Diffusion tensor imaging in Parkinson's disease: review and meta-analysis
Background Neuroimaging studies help us better understand the pathophysiology and
symptoms of Parkinson's disease (PD). In several of these studies, diffusion tensor imaging …
symptoms of Parkinson's disease (PD). In several of these studies, diffusion tensor imaging …
MR biomarkers of degenerative brain disorders derived from diffusion imaging
The incidence of neurodegenerative diseases has shown an increasing trend. These
conditions typically cause progressive functional disability. Identification of robust …
conditions typically cause progressive functional disability. Identification of robust …
Neuroimaging of Parkinson's disease: Expanding views
CP Weingarten, MH Sundman, P Hickey… - … & Biobehavioral Reviews, 2015 - Elsevier
Advances in molecular and structural and functional neuroimaging are rapidly expanding
the complexity of neurobiological understanding of Parkinson's disease (PD). This review …
the complexity of neurobiological understanding of Parkinson's disease (PD). This review …
White matter changes in Parkinson's disease
K Yang, Z Wu, J Long, W Li, X Wang, N Hu… - npj Parkinson's …, 2023 - nature.com
Parkinson's disease (PD) is the second most common neurodegenerative disease after
Alzheimer's disease (AD). It is characterized by a progressive loss of dopaminergic neurons …
Alzheimer's disease (AD). It is characterized by a progressive loss of dopaminergic neurons …
Biomarkers for dementia and mild cognitive impairment in Parkinson's disease
M Delgado‐Alvarado, B Gago… - Movement …, 2016 - Wiley Online Library
Cognitive decline is one of the most frequent and disabling nonmotor features of Parkinson's
disease. Around 30% of patients with Parkinson's disease experience mild cognitive …
disease. Around 30% of patients with Parkinson's disease experience mild cognitive …
Diffusion magnetic resonance imaging-based biomarkers for neurodegenerative diseases
K Kamagata, C Andica, A Kato, Y Saito… - International Journal of …, 2021 - mdpi.com
There has been an increasing prevalence of neurodegenerative diseases with the rapid
increase in aging societies worldwide. Biomarkers that can be used to detect pathological …
increase in aging societies worldwide. Biomarkers that can be used to detect pathological …
A metabolic profile of polyamines in parkinson disease: A promising biomarker
S Saiki, Y Sasazawa, M Fujimaki… - Annals of …, 2019 - Wiley Online Library
Objective Aging is the highest risk factor for Parkinson disease (PD). Under physiological
conditions, spermidine and spermine experimentally enhance longevity via autophagy …
conditions, spermidine and spermine experimentally enhance longevity via autophagy …
Neuroimaging in dementia
AM Staffaroni, FM Elahi, D McDermott… - Seminars in …, 2017 - thieme-connect.com
Although the diagnosis of dementia still is primarily based on clinical criteria, neuroimaging
is playing an increasingly important role. This is in large part due to advances in techniques …
is playing an increasingly important role. This is in large part due to advances in techniques …
Diffusion tensor imaging in Parkinson's disease and parkinsonian syndrome: a systematic review
Y Zhang, MA Burock - Frontiers in neurology, 2020 - frontiersin.org
Diffusion tensor imaging (DTI) allows measuring fractional anisotropy and similar
microstructural indices of the brain white matter. Lower than normal fractional anisotropy as …
microstructural indices of the brain white matter. Lower than normal fractional anisotropy as …